Association between chronic obstructive pulmonary disease and chronic kidney disease in vascular surgery patients

Nephrology Dialysis Transplantation

Volumn 24, Issue 9, 2009, Pages 2763-2767

  Van Gestel, Yvette R B M ^a   Chonchol, Michel ^b   Hoeks, Sanne E ^a   Welten, Gijs M J M ^a   Stam, Henk ^a   Mertens, Frans W ^a   Van Domburg, Ron T ^a   Poldermans, Don ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

Chronic kidney disease; Chronic obstructive pulmonary disease; Vascular surgery

Indexed keywords

ANTIDIABETIC AGENT;

ARTICLE; CHRONIC KIDNEY DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DIABETES MELLITUS; DIET; DISEASE ASSOCIATION; FEMALE; GLOMERULUS FILTRATION RATE; HEART FAILURE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; KIDNEY FUNCTION; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREVALENCE; PRIORITY JOURNAL; SMOKING; VASCULAR SURGERY;

AGED; AGED, 80 AND OVER; COHORT STUDIES; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; NETHERLANDS; PERIPHERAL VASCULAR DISEASES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS; VASCULAR SURGICAL PROCEDURES;

EID: 69249118534     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfp171     Document Type: Article

References (26)

1. Coresh J, Selvin E, Stevens LA et al. Prevalence of chronic kidney disease in the United States. JAMA 2007; 298: 2038-2047
2. Schieppati A, Remuzzi G. Chronic renal diseases as a public health problem: epidemiology, social, and economic implications. Kidney Int Suppl 2005; S7-S10
3. Elsayed EF, Tighiouart H, Griffith J et al. Cardiovascular disease and subsequent kidney disease. Arch Intern Med 2007; 167: 1130-1136
4. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med1999; 340: 115-126
5. Udani SM, Dieter RS. Inflammation in renal atherosclerotic disease. Expert Rev Cardiovasc Ther 2008; 6: 873-881
6. Lin CY, Lin LY, Kuo HK et al. Chronic kidney disease, atherosclerosis, and cognitive and physical function in the geriatric group of the National Health and Nutrition Survey 1999-2002. Atherosclerosis2009; 202: 312-319
7. Rabe KF, Hurd S, Anzueto A et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2007; 176: 532-555
8. Sin DD, Man SF.Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary disease. Circulation 2003; 107: 1514-1519
9. Engstrom G, Lind P, Hedblad B et al. Lung function and cardiovascular risk: relationship with inflammation-sensitive plasma proteins. Circulation 2002; 106: 2555-2560
10. Jousilahti P, Vartiainen E, Tuomilehto J et al. Symptoms of chronic bronchitis and the risk of coronary disease. Lancet 1996; 348: 567- 572
11. Sin DD, Man SF. Chronic obstructive pulmonary disease as a risk factor for cardiovascular morbidity and mortality. Proc Am Thorac Soc 2005; 2: 8-11
12. Celli BR, MacNee W. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 2004; 23: 932-946
13. vanGestel YR,Hoeks SE, SinDDet al. Impact of cardioselective betablockers on mortality in patients with chronic obstructive pulmonary disease and atherosclerosis. Am J Respir Crit Care Med 2008; 178: 695-700
14. Levey AS, Green T, Kusek JW et al. A simplified equation to predict glomerular filtration rate from serum creatinine. J Am Soc Nephrol2000; 11: 155A
15. Levey AS, Coresh J, Balk E et al.NationalKidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med 2003; 139: 137-147
16. Fox CS, Larson MG, Leip EP et al. Predictors of new-onset kidney disease in a community-based population. JAMA 2004; 291: 844- 850
17. Orth SR, Ritz E, Schrier RW. The renal risks of smoking. Kidney Int1997; 51: 1669-1677
18. Gan WQ, Man SF, Senthilselvan A et al. Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis. Thorax 2004; 59: 574- 580
19. Sevenoaks MJ, Stockley RA. Chronic Obstructive Pulmonary Disease, inflammation and co-morbidity-a common inflammatory phenotype? Respir Res 2006; 7: 70
20. van Eeden SF, Sin DD. Chronic obstructive pulmonary disease: a chronic systemic inflammatory disease. Respiration 2008; 75: 224- 238
21. Iwamoto H, Yokoyama A, Kitahara Y et al. Airflow limitation in smokers is associated with subclinical atherosclerosis. Am J Respir Crit Care Med 2009; 179: 35-40
22. Shlipak MG, Fried LF, Crump C et al. Elevations of inflammatory and procoagulant biomarkers in elderly persons with renal insufficiency. Circulation 2003; 107: 87-92
23. Anand IS, Chandrashekhar Y, Ferrari R et al. Pathogenesis of congestive state in chronic obstructive pulmonary disease. Studies of body water and sodium, renal function, hemodynamics, and plasma hormones during edema and after recovery. Circulation 1992; 86: 12- 21
24. Sin DD, Anthonisen NR, Soriano JB et al. Mortality in COPD: role of comorbidities. Eur Respir J 2006; 28: 1245- 1257
25. Go AS, Chertow GM, Fan D et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004; 351: 1296-1305
26. Strippoli GF, Navaneethan SD, Johnson DW et al. Effects of statins in patients with chronic kidney disease: meta-analysis and metaregression of randomised controlled trials. BMJ 2008; 336: 645- 651